Krystal Biotech, Inc. (KRYS) Earnings
|
Expand Research on KRYS
| Next EPS Date | 8/4/26 *Est. | EPS Growth Rate | -100.0% *Last Qtr. |
|---|---|---|---|
| Average EPS % Beat Rate | +34.9% | Revenue Growth Rate | -100.0% *Last Qtr. |
| Average % Move 1-Wk after EPS | -6.6% | Normal Earnings Time | Before Open |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 5/11/26 |
Q126 | N/A | $1.46 | N/A | N/A | $111.6M | N/A | N/A | N/A | ||
| 2/17/26 | Q425 | $1.70 | $1.58 | +$0.12 | $107.1M | $106.16M | N/A | ![]() | ![]() | Details | |
| 11/3/25 | Q325 | $2.66 | $1.09 | +$1.57 | $97.8M | $93.19M | N/A | ![]() | ![]() | Details | |
| 8/4/25 | Q225 | $1.29 | $1.22 | +$0.07 | $96.04M | $92.24M | N/A | ![]() | ![]() | Details | |
| 5/6/25 | Q125 | $1.20 | $1.46 | -$0.26 | $88.18M | $99.12M | N/A | ![]() | ![]() | Details | |
| 2/19/25 | Q424 | $1.52 | $1.21 | +$0.31 | $91.14M | $91.63M | N/A | ![]() | ![]() | Details | |
| 11/4/24 | Q324 | $0.91 | $0.99 | -$0.08 | $83.8M | $82.94M | N/A | ![]() | ![]() | Details | |
| 8/5/24 | Q224 | $0.53 | $0.78 | -$0.25 | $70.3M | $65.3M | N/A | ![]() | ![]() | Details |


